Coming December: ASH publishes its late-breaking abstracts. We’ll add the organizations presenting them.

Lymphoma and CLL at ASH 2026

Dec 12–15, 2026 New Orleans, LA ~30k attendees Website

656 organizations at ASH 2026 present work in lymphoma & CLL, led by hospitals and cancer centres. Between them they bring 4,703 presentations to the program. Most represented: Mayo Clinic, MD Anderson Cancer Center and Memorial Sloan Kettering Cancer Center. As of Nov 10, 2026.

All 1,934 organizations at ASH 2026 →

Format
Top represented
Showing 1–1 of 656 organizations
OrganizationASH 2026 Attendance
Mayo Clinic
Rochester, MN
Hospitals & cancer centres
Non-profit academic medical center with main campuses in Minnesota, Arizona and Florida, providing patient care, research and education.
Symposium
Fri Dec 11
11:00am–2:00pm
Actionable Approaches to AL Amyloidosis Care: Diagnosing Earlier, Treating Smarter, Managing Together
Diagnosing light-chain amyloidosis earlier, personalizing treatment including fibril-targeting drugs, supporting patients, and improving team workflows.
Myeloma
Symposium
Fri Dec 11
11:00am–2:00pm
Show Me the Data™: Emerging Evidence and Evolving Clinical Practice in Essential Thrombocythemia and Polycythemia Vera
Newer options for polycythemia vera and essential thrombocythemia, such as ropeginterferon and rusfertide, and what to do when hydroxyurea fails.
Leukemias
Symposium
Fri Dec 11
11:00am–2:00pm
Transforming Care for Newly-Diagnosed Multiple Myeloma: Integrating Evidence-Based Innovation into Community Practice
Newly diagnosed multiple myeloma care in community clinics, using frailty assessment, dose adjustment to protect quality of life, and new drug formulations.
Myeloma
Talk
Sat Dec 12
9:30am–10:45am
Running on Wheels: How Mouse Models Inform the Study of Plasma Cell Biology
Immune-competent mouse models of multiple myeloma that mimic its interplay with bone marrow, used to test new immune and cell therapies before trials.
Myeloma · Blood biology
Session
Sun Dec 13
11:30am–12:30pm
Treating Fairly Rounds Lunch
How hematologists and fellows can influence healthcare reform on research funding, Medicaid, and hospital budgets, and how policy shapes health inequities.
Patient care
Talk
Mon Dec 14
10:30am–11:45am
Older Adults Take the Lead: Revolutionizing B-cell ALL Treatment with Chemo-Sparing Approaches
Chemotherapy-light care of older adults with B-cell acute lymphoblastic leukemia, using fitness and residual disease to sequence immunotherapies and transplant.
Leukemias
Talk
Mon Dec 14
4:30pm–5:45pm
Clonal Dominance in VEXAS
An adult-onset inflammatory blood disorder caused by mutation of one protein-tagging enzyme, and how extra mutations shape inflammation and treatment.
Blood biology
Session
Mon Dec 14
4:30pm–5:45pm
Don't Miss It! Methemoglobinemia: Inherited and Acquired
How to evaluate unexplained cyanosis, recognize inherited or acquired methemoglobinemia with lab tests, and manage it without costly unnecessary workups.
Red cells
Talk
Mon Dec 14
4:30pm–5:45pm
Laboratory Testing in Methemoglobinemia
Lab diagnosis of methemoglobinemia and sulfhemoglobinemia, where altered hemoglobin carries oxygen poorly, and test pitfalls in inherited versus acquired cases.
Red cells

Explore the full ASH 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in New Orleans. Leave your work email and we’ll be in touch.

Privacy

Download the full ASH 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find buyers in lymphoma & CLL

Tell us what you sell and we’ll find the people at organizations working on lymphoma & CLL most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Browse ASH 2026 by

Exhibit hall

Not affiliated with or endorsed by the American Society of Hematology (ASH). Submit a correction